CTIX Opinions 08/19/2014 00:30:03 $CTIX Some folks better

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
CTIX Opinions 08/19/2014 00:30:03 $CTIX
Some folks better pull levers or be remembered as the man behind the green curtain. As you mention it could rocket as others Bio's before and someone not loaded could have trouble catching the ship
Looking forward to the next few weeks.

Order of Magnitude change

10x

Good luck and GOD bless,

George
Observe, the P-B-K mini-singularity is near. How will the market react? A simple stair step patern to a new, higher valuation, or an explosive magnitude of order change in price with little opportunity to load on corrections. And, what about those Big Pharma MTAs? Was Leo pumping, or was he "just sayin" 7 months ago?
Wild4 makes an appearance. Tell us did we make equivalence or superiority? Tell us tell us!!??
LOL

Wild we know you have a copy of the results by now
Same here ...just curious/ little worried about how high / how long will we go on "expectations of news" versus the actual real thing. ..
" Buckle Up " Boys and Girls ! Hitting the pillow and will see you all mañana on our lovely CTIX message board. I know no more than anyone else but I sure believe this volume is indicating something that could be compelling for all us committed longs. Just my opinion and we'll see ....as always " Buyer Beware " !

GO CTIX !
That is some very nice technical work noretreat. Thanks for posting it. CTIX
"Should have loaded up at 1.71 oh well"

You meant $1.40?
DaubersUp and anyone there in person would be slamming the BUY button on their trading account while the disco ball was spinning.
That's funny stuff
Good post, not that any of us follow the technicals at all, the technical's will lead then the fundamentals follow..............And gotta love our new mascot, I mean our new Dr, Dr Rally, LOL.
You just blew my mind broooooooooHh.....
I enjoy your posts and humor.
I also agree and believe we are and have been ignored based on share price including history. I hope this is the start...

B
My best guess is he will report that the higher single dose is equal to Dapto, then the SP will do what that dog in my siggie did: while on the way to the moon, knock out a space walker (space walker is a metaphor for short interest).
A Birthing Day wish for me for sure-would be a perfect gift that would keep on giving for a long time.??
So you are saying there is a chance!!!! Ha. Maybe prelim B report stating it is non-inferior to Dapto...or was it superior...? Lol

As Leo announces this and states one more time just to here an echo of his own voice...he states this first in class antibiotic is non resistant!!! Yes...he said the likelihood of building resistance is almost zero percent! And it outperformed a billion dollar revenue producing drug.

And then the lights dim and a disco ball drops to a slide that shows the p21 data from cohort 8 and a linear chart that correlates exactly what they saw in preclinical data.....BOOM!

Will this all happens on Sept 9th?!?!

Daubs dreams



Hopefully can pick up more shares later this week as profit taking creates a new
buying opportunity.
Should have loaded up at 1.71 oh well
TD where is Wild4? Perhaps sitting with Leo and Menon reviewing trial details!!!??? LOL!!
Quite a few had moved on to other stocks for the period they felt CTIX would remain sideways. There are enough upcoming catalysts to start luring them back now. Most that like the company don't want to be out. Just basing that on personal conversations.

It could be almost anything. No way to know for sure what moved it today. But, I'm holding since I like the way the company has been moving forward.




In Reply to 'Matagordaville'
Karin would you venture an opinion on today's volume. One particular key item like the b trial results upcoming, multiple catalysts aligning, leaks, or something beyond simple retail, etc

Looking forward to the upward charge tomorrow

Let's do it Leo !!!!




Ease up there. Let's not go overboard on predictions. Go CTIX!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 40

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 11

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading
Firehawk Defense Secures $150M, Valuation Hits $1.4B

Updated Category News Views 36

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Continue Reading
Vertiv's Explosive Q3 Growth: A 2026 Power Move

Updated Category News Views 30

Vertiv's Third Quarter Triumph Imagine a company blowing past expectations like a hot knife through butter—yeah, that's Vertiv for you in 2026. These guys didn’t just ride the wave; they created a tsunami in the digital infrastructure sector. Net sales ballooned by a staggering 61% compared to last year's same quarter, pulling in $4.313 billion. When you consider the...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 38

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 18

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Right College Fit Crucial for Graduation Rates

Updated Category News Views 60

Navigating College Choices: More Than Just a Hunch When it comes to picking the right college, a lot of folks think it's like shooting in the dark—it's more than just a blind dart throw at a life map. According to a new report from the College Board, aligning with the right academic institution isn't merely a nice-to-have deal; it fundamentally shifts the odds in favor...

Continue Reading
GeoComm and Rypplzz Team Up for 3D Mapping Breakthrough

Updated Category News Views 45

Cracking the Mystery of Multilevel Locations Let me tell you, when lives hang in the balance, every second counts. We've all seen the chaos when first responders are trying to pinpoint someone's location inside a building with more floors than a loaf of bread. Enter GeoComm and Rypplzz, the new superheroes in this story. These two companies have realized the opportunity...

Continue Reading
Probiotics in Animal Feed: Market Reaches $8.76B by 2031

Updated Category News Views 14

Let's cut straight to the chase: the probiotics in animal feed market is steaming ahead, set to grow from a respectable $5.82 billion in 2026 to a hearty $8.76 billion by 2031. We're talking about a solid CAGR of 8.5% here. Now that's the kind of growth trajectory that gets even the most jaded traders sitting up and taking notice. Big Numbers in Livestock Nutrition...

Continue Reading
JELD-WEN Kicks Off 2027 Senior Notes Exchange

Updated Category News Views 22

A Fresh Play: Swapping Old for New With a fresh brew in hand and the latest company maneuvers on the table, JELD-WEN's move to exchange its 4.875% Senior Notes due 2027 for new secured notes maturing in 2031 comes into focus. This ain't just some routine shuffling of papers. They're calling up eligible folks holding onto those old notes, saying, 'Why stick with the old...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Seamless Customer Experience: Insights from Info-Tech

Updated Category News Views 159

Transforming Customer Engagement with Omnichannel Strategies In an era where digital interactions dominate, businesses are increasingly feeling the strain of disjointed customer experiences. Despite investing heavily in digital tools, many organizations find themselves navigating a labyrinth of disconnected channels, leading to frustrating customer journeys. Info-Tech...

Continue Reading
Bulat Utemuratov Foundation Provides Housing for Families in Need

Updated Category News Views 170

Bulat Utemuratov Foundation Provides Housing for Families in Need The Bulat Utemuratov Foundation has recently made a significant commitment to providing housing for families in need by donating 500 apartments to the local government of Astana. This generous contribution, valued at an impressive 10.5 billion tenge, is part of the Foundation's broader charitable initiative...

Continue Reading
Discover the Journey of a $100 Investment in AbbVie Stock

Updated Category News Views 170

The Growth of AbbVie: A Decade of Investment AbbVie (NYSE: ABBV) has shown impressive performance in the stock market, consistently outpacing market averages. Over the last decade, AbbVie has delivered an average annual return of 15.43%, exceeding general market returns by 2.87%. With a market capitalization nearing $406.27 billion, AbbVie stands as a significant player...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 122

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Experience Romer's Premier Baby Gear at Strolleria Event

Updated Category News Views 207

Join Romer for an Exclusive In-Store Event Romer, recognized for its premium baby gear designed for families, is thrilled to invite expectant parents, families, media, and influencers to an exciting event. This occasion will take place at Strolleria, a revered destination for baby products, and showcases Romer's elegant and safe gear. Details of the Event The event will...

Continue Reading